Eksaminator: Ph.d.-forsvar Odd Lilleng Gammelgaard: Development and evaluation of novel antibody-based targeting strategies of CD73 for cancer treatment

Aktivitet: Censoraktivitet, eksaminering og ekstern vejledningIntern eksaminator

Periode9. dec. 2019
EksaminandOdd Lilleng Gammelgaard